Document is current
Any future updates will be listed below
-
Authors
Wu, Xiaoning
Hong, Jia
Zhou, Jialing
Sun, Yameng
Li, Lei
Xie, Wen
Piao, Hongxin
Xu, Xiaoyuan
Jiang, Wei
Feng, Bo
Chen, Yongpeng
Xu, Mingyi
Cheng, Jilin
Meng, Tongtong
Wang, Bingqiong
Chen, Shuyan
Kong, Yuanyuan
Ou, Xiaojuan
You, Hong
Jia, Jidong https://orcid.org/0000-0002-4673-8890
-
Funding
Funding for this research was provided by:
National Science and Technology Major Project (2018ZX09201016, 2018ZX10302204-004, 2017ZX10203202-003)
the Project of Beijing Municipal Science and Technology Commission (D161100002716003)
Project of the Digestive Medical Coordinated Development Center of Beijing Hospitals Authority (XXZ0405)
- License Information
-
More Information
Article History
Received: 2 May 2021
Accepted: 20 July 2021
First Online: 29 November 2021
Declarations
:
: Jidong Jia has provided consulting to BMS, Gilead, GSK, J&J and Roche, has received research support from Gilead, and is currently principle investigator of Brii Biosciences and Huahui Health Ltd. Hong You has provided consulting to and participated in clinical trials of J&J, Aligos, Brii Biosciences, Huahui Health Ltd, and Suzhou Ribo Life Science Co., Ltd.
: The clinical trial and long-term follow-up study were conducted following the ethical principles enshrined in the Declaration of Helsinki and complied with Good Clinical Practice guidelines and the applicable local regulatory requirements. Each patient provided written informed consent before participation. The studies were registered with the ClinicalTrials.gov identifier NCT01943617 and NCT02849132.
